GeneralConnection.com ➔ Dictionary
Dictionary Search

indolent

Synonyms

Adjective

1. faineant

2. lazy, otiose, slothful, work-shy, idle, inactive

Usage
ASH 2025 | Congress coverage: Indolent and mantle cell NHL - Lymphoma Hub
How Promising Are Immunotherapy Combos in Indolent Lymphoma? - CancerNetwork
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 - The ASCO Post
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas - The New England Journal of Medicine
Long-Term Avapritinib Use Improves Bone Health Regardless of Concomitant Anti-Osteoporosis Therapy in Indolent SM - OncLive
New Phase 2 Study of Tri-Modal Immunotherapy for Indolent B-Cell Lymphoma Launches - Targeted Oncology
Nemolizumab as an Alternative Therapeutic Option for Indolent Systemic Mastocytosis - Cureus
Ominous-appearing serosal findings on PSMA imaging might belie indolent clinical course - Nature
Avapritinib Demonstrates Durable Improvements in Indolent Systemic Mastocytosis Symptoms, QoL - HCPLive
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis - PR Newswire
Avapritinib Benefit Persists at 3 Years for Indolent Systemic Mastocytosis - Oncology News Central
Understanding Targeted Therapy for Indolent Systemic Mastocytosis - Healthgrades Health Library
How Will Indolent Lymphoma/B-Cell NHL Care Be Improved in the Future? - CancerNetwork
Dr Tashi on Updated Efficacy Data for Avapritinib in Indolent Systemic Mastocytosis - OncLive
Avapritinib Yields Sustained Symptom Reduction and Safety in Indolent SM - OncLive
Phase 2 Trial Will Evaluate CD19 t-haNK Combo in Indolent Lymphomas - CancerNetwork
Elenestinib May Be Safer Than Traditional KIT Inhibitors in Indolent Systemic Mastocytosis - OncLive
HARBOR Trial Aims to Further Elucidate Potential Role for Elenestinib in Indolent Systemic Mastocytosis - OncLive
Dr Radia on the Continued Investigation of Elenestinib in Indolent Systemic Mastocytosis - OncLive
Dr Tashi on the Effect of Avapritinib on Long-Term Bone Health in Indolent Systemic Mastocytosis - OncLive
Indolent Tumour of the Upper Lip: A Case of Lobulated Acinic Cell Carcinoma - Cureus
Blueprint’s rare disease drug Ayvakit shows long-term benefit - European Pharmaceutical Review
What's New In Treating Indolent Systemic Mastocytosis? - Healthgrades Health Library
Shift in secretory profile of a pNET: from indolent glucagonoma to aggressive insulinoma – a case report - Frontiers
Eliezer Van Allen: How Liposarcomas Switch From Indolent to Lethal States - Oncodaily
Current Standards of Care to Treat Patients With Indolent Systemic Mastocytosis - HCPLive
Looking Ahead in Indolent Systemic Mastocytosis Treatment: Data Gaps and Hope for a Cure - HCPLive
‘Indolent and not photogenic’: can I make my reluctant cat a social media star in seven days? - The Guardian
The Clinical Significance of a Durable Treatment for Indolent Systemic Mastocytosis - HCPLive
Understanding Indolent Systemic Mastocytosis (ISM): Symptoms and Impact - HCPLive
Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight - Yahoo Finance
Considerations for Renaming Indolent Prostate Cancer in Different Practice Settings - Matthew Cooperberg & Nicolás Villareal Trujillo - UroToday
Avapritinib Offers Sustained Benefit in Indolent Systemic Mastocytosis - HCPLive
The Heterogeneous Clinical Presentations of Indolent Systemic Mastocytosis - HCPLive
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas - Business Wire
What to Know About Tyrosine Kinase Inhibitors for Indolent Systemic Mastocytosis - Healthgrades Health Library
18th International Conference on Malignant Lymphoma (ICML) congress coverage | Indolent and mantle cell NHL - Lymphoma Hub
San Diego workshops to focus on indolent systemic mastocytosis - Times of San Diego
ImmunityBio Launches Phase 2 Chemotherapy-Free CAR-NK Cell Therapy Trial with ANKTIVA® (ResQ215B) in Indolent Lymphomas - BioSpace
EHA 2025 | Indolent and mantle cell NHL - Lymphoma Hub
Treatment Breakthroughs for Indolent Systemic Mastocytosis - Healthgrades Health Library
Effective venetoclax treatment for indolent T-cell lymphoma of the gastrointestinal tract: a case report and literature review - Frontiers
Indolent Abdominal Wall Round Cell Sarcoma With EWSR1-PATZ1 Fusion: A Case Report and Literature Review - Cureus
Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting - PR Newswire
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial - The Lancet
A missive from the Courthouse Democrats - Daily Kos
Indolent Cutaneous B-Cell Lymphomas Mimic Persistent Antigen Reactions - BIOENGINEER.ORG
"Lethargic, Tardy and Indolent," Supreme Court Pulls Up Odisha Govt For 4 Months Delay in Filing SLP - LawBeat
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas - GlobeNewswire
Indolent Systemic Mastocytosis Treatment Market Size Analysis - Market.us Media
Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight - 富途牛牛
Avapritinib versus Placebo in Indolent Systemic Mastocytosis - NEJM Evidence
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy - The New England Journal of Medicine
Many Patients with ISM Have Lower Survival - Cleveland Clinic
Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract - Haematologica
Lethargic, Tardy & Indolent: SC Rebukes Odisha Govt For Delay In Filing SLP - OdishaBytes
Identification of superficial invasive and indolent lymphomatous lymph nodes by multiple ultrasonographic vascular imaging - Nature
To Our Indolent Cancer | Greg Delanty - The New York Review of Books
Avapritinib Leads a Charge of Novel Targeted Therapies for Indolent Systemic Mastocytosis - OncLive
Monjuvi scores a qualified indolent lymphoma success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis - Haematologica
Indolent Systemic Mastocytosis’ Diagnostic Clues, with Patricia Lugar, MD - HCPLive
Indolent nodal T follicular helper cell lymphomas—A case series - Blood Cancer Journal - Nature
FDA Approves Avapritinib for Indolent Systemic Mastocytosis - OncLive
FDA Approves Avapritinib in Indolent Systemic Mastocytosis - CancerNetwork
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy - The New England Journal of Medicine
Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model - Nature
Beyond Serum Tryptase: Exploring Additional Testing Approaches for Indolent Systemic Mastocytosis - OncLive
A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma - Hospital Clínic Barcelona
The Remaining Role for Radioimmunotherapy in Indolent Lymphoma - ASCO Daily News
Defining Indolent Relapse Multiple Myeloma - Pharmacy Times
Axi-Cel Efficacy in R/R Indolent Non-Hodgkin Lymphoma Sustained at 5 Years - Targeted Oncology
Dr. Goy on the Clinical Implications of Treating Indolent MCL - OncLive
More Treatments for Indolent Lymphoma in Clinic Soon? “Exciting Updates” From ASH 2024 - Oncology News Central
Bispecific antibodies in indolent B-cell lymphomas - Frontiers
Neuroendocrine Carcinoid Lung Tumor: A Case Series of an Indolent Tumor - Cureus
Breyanzi Improves Responses in R/R Indolent B-Cell Non-Hodgkin Lymphoma - CUREtoday.com
Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single-Cell Transcriptomics - Wiley
The Indolent Nature of Chronic Lymphocytic Leukemia - CUREtoday.com
Clinical and Molecular Features May Predict Indolent Chronic Myelomonocytic Leukemia - Cancer Therapy Advisor
Advances in Lymphoma Research - National Cancer Institute (.gov)
Indolent Metastatic ccRCC Disease Progression and Guideline Updates - Targeted Oncology
Court officials suspended for drug trafficking, forgery, stealing; indolent Sharia judge gets warning - Peoples Gazette Nigeria
Response-Adapted Radiation Therapy for Orbital Indolent B-Cell Lymphoma - The ASCO Post
Indolent pocket wound in a cat - Vet Times
Response-adapted ultra-low dose radiation achieves complete response in 90% of patients with orbital indolent B-cell lymphomas - UT MD Anderson
Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era - Nature
Addition of Copanlisib to Rituximab Improves Progression-Free Survival in Relapsed Indolent Non-Hodgkin Lymphoma - The ASCO Post
Study Supports Bendamustine-Rituximab as Standard-of-Care in Patients With Indolent Non-Hodgkin Lymphoma - Pharmacy Times
Ultra-Low-Dose Radiation Appears Effective in Orbital Indolent B-Cell Lymphoma - Cancer Therapy Advisor
T‐PLL Presenting with an Indolent Course - Thammahong - 2024 - Case Reports in Hematology - Wiley Online Library
Nearly One-Fifth of Screened Lung Cancer Cases May Be Indolent - CancerNetwork
Very Low Dose Radiation Therapy Demonstrates Efficacy in Indolent Non-Hodgkin Lymphoma - OncLive
Ultra-Sensitive Duplex Sequencing Improves Diagnostic Capabilities in Indolent Systemic Mastocytosis - OncLive
Blueprint Medicines' AYVAKYT® (avapritinib) Receives European Commission Approval as the First and Only Treatment for Indolent Systemic Mastocytosis - PR Newswire
Cookie Run: Kingdom - Best Toppings & Beascuits For Eternal Sugar Cookie - Screen Rant
Recurrent Indolent Keratitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review - Cureus
Blueprint Medicines Announces FDA Acceptance of Supplemental New Drug Application for AYVAKIT® (avapritinib) for the Treatment of Indolent Systemic Mastocytosis - PR Newswire
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial - The Lancet
Exploring Novel Combinations in Indolent Lymphomas - Targeted Oncology
Foreign Language Equivalents
Foreign Language Equivalents of 'indolent'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
indollent,   indo;ent,   indplent,   indolentt,   idnolent,   ibdolent,   iindolent,   indolenr,   indolwnt,   indolet,   inolent,   indoleent,   indokent,   insolent,   idolent,   infolent,   indolnt,   indolrnt,   indolennt,   indoletn,   indoleny,   indolemt,   nidolent,   ondolent,   indlent,   indolen,   undolent,   imdolent,   indolnet,   inndolent,   ndolent,   inodlent,   indoelnt,   inddolent,   indoent,   indilent,   indolebt,   indoolent,   indloent
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z